---
title: "Efficacy Assessment of Targeted Therapies and Immunotherapies for Melanoma Using Ex Vivo Patient-Derived 3D Tumour Spheroids"

event: ESMO Congress 2023
event_url: https://www.esmo.org/

location: Madrid, Spain
address:
  city: Madrid
  country: Spain

summary: Poster presentation at the European Society for Medical Oncology (ESMO) Congress 2023, Madrid â€” presenting ex vivo drug efficacy data from patient-derived melanoma spheroids.

abstract: |
  Poster presentation of the EVIDENT study's early findings on ex vivo drug response profiling in patient-derived 3D melanoma spheroids. The study evaluated targeted therapies (BRAF/MEK inhibitors) and immunotherapy (anti-PD-1) agents in a personalised medicine framework. Abstract published in Annals of Oncology (2023), DOI: 10.1016/j.annonc.2023.09.1329.

date: '2023-10-20T09:00:00Z'
date_end: '2023-10-24T17:00:00Z'
all_day: false

publishDate: '2023-10-20T00:00:00Z'

authors:
  - admin

tags:
  - Cancer Research
  - Immunotherapy
  - Melanoma
  - ESMO
  - Targeted Therapy
  - Poster Presentation

featured: true

image:
  caption: 'ESMO Congress 2023, Madrid, Spain'
  focal_point: Smart
  # To add your image: place a file named "featured.jpg" or "featured.png"
  # in this folder: content/event/esmo-2023/

url_slides: ''
url_pdf: ''
url_video: ''
url_code: ''

links:
  - name: Abstract (Annals of Oncology)
    url: https://doi.org/10.1016/j.annonc.2023.09.1329
    icon_pack: ai
    icon: doi

projects:
  - evident-cancer-screening
---

**Presentation type:** Poster

**Event:** ESMO Congress 2023

**Venue:** Madrid, Spain ðŸ‡ªðŸ‡¸ Â· October 2023

Poster presented at the European Society for Medical Oncology (ESMO) Annual Congress â€” one of the world's leading oncology conferences. Abstract published in *Annals of Oncology*, Vol. 34, Supplement 2 (2023).

> To add a photo from this conference, place an image file named `featured.jpg` or `featured.png` in this folder (`content/event/esmo-2023/`).
